The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose escalation and expansion results from the phase I study of F0024, a trophoblast cell-surface antigen 2 (TROP2) antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors.
 
Yiqun Du
No Relationships to Disclose
 
Yanchun Meng
No Relationships to Disclose
 
Jingfen Wang
No Relationships to Disclose
 
Ying Wang
No Relationships to Disclose
 
Fan Wu
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Lilin Chen
No Relationships to Disclose
 
Lihua Qing
Employment - Department of Medicine, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
 
Yaya Qiao
Employment - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
 
Kezhen Liu
Employment - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
 
Wenyi Sun
Employment - Department of Medicine, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
 
Xiaowen Li
Employment - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Leadership - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
 
Jian Zhang
No Relationships to Disclose